Framework to Accelerate Substance Use Disorder Genetic Studies through Customizable, EHR-Based Precision Phenotyping
Framework to Accelerate Substance Use Disorder Genetic Studies through Customizable, EHR-Based Precision Phenotyping
批准号:
10512420
负责人:
Alvin Dean Jeffery
金额:
$47.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2027-07-31
关键词:
AlcoholsBasic ScienceBiologicalClinical Decision Support SystemsClinical ResearchCodeComplexComputer softwareCustomDataData SourcesDevelopmentDiseaseDisease ManagementDrug usageElectronic Health RecordFoundationsGeneticGenetic studyGoalsHealthIndividualInterventionKnowledgeLabelLinkMethodsNational Institute of Drug AbuseOpioidOutcomePharmaceutical PreparationsPhenotypePreventionPublic HealthResearchResearch PersonnelServicesSpecific qualifier valueSubstance Use DisorderSystemTextTobaccoVariantWorkbaseclinical carecostdisorder preventiongraphical user interfaceheuristicsinnovationlarge datasetsneurobiological mechanismnovelpolygenic risk scoreportabilitypreventive interventionprospectivesubstance use treatment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
There is a critical need for accurate, efficient, and portable substance use disorder (SUD) identification
methods that support large-scale genetic studies in uncovering biological mechanisms helpful in SUD
prevention and management. The long-term goal of this work is to support genetic discovery efforts that result
in beneficial interventions for prevention and treatment of SUD. The overall objective in this proposal is to
develop and evaluate an SUD phenotyping method that allows investigators to fine-tune phenotypes for their
specific projects. Given most large-scale SUD phenotyping for genetics studies have relied on administrative
billing codes (that undercount true cases) and binary outcome labels (that induce arbitrary dichotomization),
the rationale for this project is that a system which includes a variety of data sources and generates a
probabilistic outcome along a continuum is needed. The SUD phenotyping framework will support the inclusion
of heterogenous electronic health record data types (including administrative billing codes, medication
information, and unstructured text data) and will be evaluated in multiple organizations. Pairing these SUD
phenotypes with genetic data will enhance our understanding of SUD mechanisms among individuals. That
foundational work could ultimately result in the development of polygenic risk scores and clinical decision
support systems that we could implement prospectively in clinical care. The proposed research is significant
because researchers have a pressing need for SUD phenotyping approaches that can be customized to their
research focus and available data. This proposal’s innovation lies in the creation of a “self-service” approach to
SUD phenotype development in which a research team can specify their own phenotype definitions. The
software will have a graphical user interface that makes the highest-yield rules/heuristics the easiest to use
and can therefore be used by investigators with basic scientific programming knowledge. Through the activities
outlined above, this innovation will directly accelerate genetic studies of SUD while simultaneously developing
a precision phenotyping framework that can be applied to other disease domains.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Framework to Accelerate Substance Use Disorder Genetic Studies through Customizable, EHR-Based Precision Phenotyping
-
批准号:10670983
-
项目类别:
-
资助金额:$47.55万
-
财政年份:2022
-
负责人:Alvin Dean Jeffery
-
依托单位:
海外基金